After Pfizer’s vaccine data, analysts say COVID drug makers face questions about long-term sales prospects

After Pfizer’s vaccine data, analysts say COVID drug makers face questions about long-term sales prospects
esagonowsky
Mon, 11/09/2020 – 11:09